Paths of Progress 2020
A selection of articles from the 2020 issue of Paths of Progress.
To see the entire publication, please download the PDF version. If you'd like to receive a print version of Paths of Progress in the mail, please complete this form.
Articles
A Case for Curiosity
Tracing the circuitous path that led to the 2019 Nobel Prize in Physiology or Medicine for Dana-Farber's William Kaelin Jr., MD.
Unexpected Benefits from Targeted Therapies
New research shows that CDK 4/6 and PARP Inhibitors can stimulate the immune system to fight cancer, in addition to their known effects in fighting tumor cells.
Shapeshifters in the Brain
Understanding how aggressive brain tumors evade treatment with new technology that examines genetic information within individual cells, one at a time.
Bringing AI to Personalized Cancer Care
Machine language technology brings the new capability to study each individual's risks and best treatment options.
Liquid Biopsies Move Toward the Clinic
Chemical biologists create small molecules to boost discoveries and prototype novel therapies.
Request a Publication
Receive by mail the current issue of a Dana-Farber publication by completing this request form.
Media Contacts
If you are a journalist and have a question about any of our stories or need more information, email media@dfci.harvard.edu or call 617-632-4090 and ask to speak to a member of the media team.
The Media Team cannot respond to patient inquiries. For more information on contacting Dana-Farber, please see Contact Us.
Disclosure of Advisory Roles and Certain Industry Support
See an overview of relevant board memberships, outside support, and significant advisory roles as reported by several physicians and researchers featured in the 2020 issue of Dana-Farber's Paths of Progress magazine.